Withdrawal from chronic use of psychostimulant drugs in hI/mans induces a clinical syndrome characterized by fatigue, psychomotor depression, anhedonia, and disturbances of sleep. Spontaneous locomotor activity and CIIJIl epsy were assessed in rats during withdrawal from a rhedule of intravenous self-administration of high doses � amphetamine. At 2 and 4 days after cessation of Imphetamine self-administration, rats showed a state of psychom otor retardation as measured by reduction of locomotor activity and increased catalepsy. In search of a f»SS ible pharmacologic means of intervention for such lEY WORDS: Amphetamine; Drug self-administration; Dopamine; Animal models of depression; Lisuride; Psychostimulant withdrawal
behavioral changes, the effect of repeated treatment with the nonaddictive ergot derivative lisuride during the withdrawal phase was evaluated. At a dose devoid of any effects on locomotor activity, lisuride completely prevented the reduction in locomotor activity and the increase in catalepsy produced by amphetamine withdrawal. These results suggest the need for further studies on lisuride as a possible novel treatment during withdrawal from psychostimulant drugs in humans. [Neuropsychopharmacology 8:213-218, 1993J with intense craving for the drug: such symptomatology usually encompasses various phases of withdrawal and lasts for a few weeks (Gawin and Kleber, 1986) . Epi sodes of craving for the abused drug are particularly pronounced and are considered to be one of the major motivating factors leading to relapse in the addictive process. It is also believed that withdrawal dysphoria may contribute, as a negative reinforcer, to drug seeking behavior. In accordance with this hypothesis, it is possible that the neural substrates of the limbic fore brain responsible for drug reward may also mediate, to some extent, withdrawal dysphoria (Pulvirenti et al. 1991) . Finally, only tricyclic antidepressants have, to date, proven clinically efficacious in reducing with drawal depression, with bromocriptine, a dopamine (DA) agonist, showing some efficacy in reducing crav ing for cocaine (Dackis and Gold 1985a; Gawin and Kle ber 1984; Tennant and Sagherian 1987) .
Lisuride is a nonaddictive ergot derivative known to stimulate postsynaptic DA receptors (Uzumaki et al. 1982; Horowski and Wachtel 1976; Schechter 1984; Rosenfeld and Makman 1981) . In a recent study, it was suggested that lisuride may reduce intravenous cocaine self-administration in rats (Pulvirenti and Koob submit ted) . This is in accordance with previous fIndings sug gesting a critical role for dopamine in the maintenance of intravenous psychostimulant self-administration in various species (Markou and Koob 1992; Roberts and Vickers 1984; Roberts et al. 1977 Roberts et al. , 1980 . In addition, ex perimental and clinical studies have suggested that a state of DA depletion may occur during cocaine with drawal (Wyatt et al. 1988; Gawin and Kleber 1985; Dackis and Gold 1985b) . A DA agonist would therefore be expected to exert a normalizing action on the endog enous DA tone temporarily disrupted by repeated expo sure to amphetamine.
The aim of the present study was: 1) to quantify the psychomotor retardation that follows withdrawal from chronic intravenous self-administration of high doses of amphetamine, and 2) to study the effect of treatment with lisuride after drug discontinuation on such behavioral abnormalities.
The results presented here show that withdrawal from self-administration of high-dose intravenous am phetamine induced reduction of spontaneous locomo tor activity and increased catalepsy, and the develop ment of this syndrome was prevented by repeated treatment with lisuride.
MATERIALS AND METHODS
Male Wistar rats (Charles River, Kingston, NY), weigh ing between 200 and 225 g at the start of the experiment, were housed three to a cage and provided with ad libitum access to food and water and maintained on a 12-hour light/dark cycle (lights on from 4:00 A.M.-4:00 P.M.).
All animals for self-administration studies were sur gically prepared under halothane anesthesia with a chronic silastic catheter implanted into the external jugular vein. The catheter/polyethylene assembly con sisted of silastic tubing attached to a guide cannula that was bent at a right angle. This junction was glued and the guide cannula was embedded into a l-inch square of marlex mesh that was secured with silex. The cathe ter was passed subcutaneously from the rat's back to the jugular vein where it was implanted. The polyeth ylene assembly was then mounted on the animal's back. A stylet was inserted into the guide cannula protrud ing from the animal's back to maintain a closed system and, therefore, prevent clogging of the cannula.
For self-administration testing, a cannula-connector assembly that was connected to a swivel and syringe pump as described by Roberts et al. (1977 Roberts et al. ( , 1980 was NEUROPSYCHOPHARMACOLOGY 1993-VOL. 8, NO.3 attached to the polyethylene assembly mounted on the animal's back immediately prior to the start of each ses sion. The cannula connector was removed following the completion of a self-administration session and replaced with the guide cannula stylet.
Four days following surgery, 14 rats were allowed 15-hour access every day (5:00 P.M. to 8:00 A.M.) for 10 days to a metal lever mounted on the side wall of a stan dard operant-conditioning cage. The cages themselves were housed inside sound-attenuating chambers. A le ver press resulted in an intravenous injection of 0.1 ml of d-amphetamine sulphate (0.12 mg/kg per injection, or 0.325 J.1mollkg per injection) dissolved in 0.9% phys iologic saline and delivered over a period of 4 seconds. A swivel system allowed free movement of the animal in the cage. Coincident with the onset of the injection, a stimulus light was illuminated for 20 seconds during which time the lever pressing did not result in reinforce ment. Lever presses during the period when the signal light was not lit were reinforced on a continuous rein forcement schedule. Control rats (n = 11) were injected with an equal volume of passive intravenous physio logic saline infusion by an experimenter.
Following completion of the 10-day self-adminis tration period, spontaneous locomotor activity was tested on days 1, 2, and 4 during withdrawal. Since loco motor testing was performed during the dark phase (5:00 P.M. to 8:00 A.M.) and the last self-administration session ended at 8.00 A.M., day 1 of withdrawal actu ally corresponded to 33 hours after the end of intrave nous self-administration. Photobeam interruption was recorded for 180 minutes in photocell cages as described previously (Joyce and Koob 1981) .
A separate group of 24 rats was used in the second part of the study. Sixteen rats were trained to self administer amphetamine as described above; eight rats received experimentally administered saline as de scribed above. At the end of the 10-day self-admini stration period, the amphetamine rats were treated with either lisuride (n = 8) (0.2 mg/kg IP, or 0.44 J.1mollkg) or saline (n = 8) (1 ml/kg IP) twice daily at (8:00 A.M. and 8:00 P.M. for 4 days).
For the study designed to test the effect of such repeated treatment with lisuride on spontaneous loco motor activity in naive rats, four animals were injected with one of four different doses of lisuride (0, 0.05, OJ, and 0.2 mg/kg IP, or 0, 0.11, 0.22, and 0.44 J.1mollkg, respectively, n = 16 rats) twice daily at 8:00 A.M. and 8:00 P.M. for 4 days. Animals were then tested as de scribed above. The injection schedule was chosen to avoid the peak effect of lisuride action during locomo tor testing.
Catalepsy testing was performed in the same rats during day 4 of withdrawal, at the end of the locomo tor testing. Both forepaws of each rat were placed on hats. The average intake was 7.37 mg/kg.
i bar 9 cm from the floor. The time elapsed until each lit repositioned both forepaws on the floor was re corded by an experimenter blind to the treatment.
Results were compared using a two-way analysis livariance with repeated measures, followed by post hoc Newman-Keul's test or a Student's t-test, where 'PJll' opriate.
The d-amphetamine sulphate was obtained from SIGMA (St. Louis, MO), lisuride hydrogen maleate was igenerous gift of Schering AG, (Berlin, Germany). All drugs were dissolved in physiologic saline solution.
RESULTS
lis that were allowed 15-hour daily access to intravenous III phetamine self-administration showed a drug intake ranging between 5.9 and 9.6 mg/kg, with an average m7.37mg/kg (Fig. 1) . Following cessation of this sched ale of drug self-administration, spontaneous locomotor activity was signifIcantly lower in rats withdrawing from amphetamine self-administration, compared to control animals ( Fig. 2) . Analysis of variance revealed that there was a main effect of treatment (F = 9.49, dt = 1,23, p < 0.01), a main effect of time (F = 14.49, dt = 2,23, p < 0.01), and no signifIcant treatment x time interaction (F < 1, dt = 2,46, NS). Comparison at the various levels revealed that statistical signifIcance was reached at day 2 (F = 9.41, dt = 1,23, p < 0.01) and day 4 (F = 5.79, dt = 1,23, p < 0.05). Similarly, amphetamine-treated rats showed increased catalepsy compared to control animals. (Fig. 3) , as measured by the bar test (t = -2.21, dt = 23, p < 0.05).
The second part of the study was designed to as sess the effect of lisuride administered during the with drawal phase on the behavioral changes observed dur ing the fIrst part of the study. The control experiment illustrated in Figure 4 shows that chronic (4-day) treat- Values represent mean ± SEM (n = 8 per group) of total pho tobeam interruption during 180 minutes. 'p < 0.05 vs.
control.
ment with lisuride per se, at the schedule employed, did not affect spontaneous locomotor activity. There was no main effect of drug (F < 1, dt = 3,12, NS), a main effect of time (F = 25.75, dt = 2,12, P < 0.01), and no signifIcant drug x time interaction (F < I, dt = 6,24, NS). In contrast, repeated treatment with lisuride (0.2 mg/kg IP) during withdrawal (Fig. 5) completely reversed the reduction of locomotor activity induced by cessation of amphetamine availability (F = 10.47, dt = 2,91, P < 0.001). Comparison at the various levels revealed that statistical signifIcance was reached at day 1 (F = 3.447, dt = 2,28, P < 0.05), day 2 (F = 4.525, dt = 2,28, p<0.05), and day 4(F = 3.87, dt = 2,28, p<0.05). This was accompanied by reversal of the postamphet amine increased catalepsy in the same rats (F = 4.01, dt = 2,21, p < 0.05) (Fig. 6) .
DISCUSSION
Withdrawal from a chronic schedule of intravenous self administration of high dose amphetamine induced a state of psychomotor retardation as measured by reduc tion of spontaneous locomotor activity and increased catalepsy. Treatment with lisuride after amphetamine suspension completely prevented the development of such behavioral changes. Abrupt cessation of chronic administration of psy chostimulant drugs in man is followed by a clinical syn drome that includes depression of mood, anhedonia, and disturbances of sleep (Gawin and Kleber 1986) . Un like other forms of depression, the occurrence of these symptoms is fairly predictable and limited in time but, similarly to endogenous depression, can be reversed by the administration of tricyclic antidepressants (Ga win and Kleber 1984). When comparing nonhuman models of "depression" to the course of the affective disorder in humans, usually little or no parallelism can be drawn between the natural history preceding hu man depression and the experimental procedure used to induce the behavioral state of" depression" in animals (Willner 1984) . In contrast, the present study provi des an animal model of depression that is drug-induced, quantitatively measurable, and has, at the same time, construct and face validity (Willner 1984) . Several studies over the past few years have ad dressed the issue of postamphetamine depression in animals. Withdrawal from a chronic schedule of experi· menter-administered amphetamine has been shown to induce a variety of behavioral changes including re duced rate of responding for electrical self-stimulation reward in rats (Kokkinidis et al. 1986 ) and elevation of its threshold (Cassens et al. 1981) , depression of general activity in rats and cats (Tonge 1974; Feinberg and Ir win 1961) , diminished reaction to novel stimuli (Kok kinidis and Anisman 1978), and increased immobility in a forced-swim situation (Kokkinidis et al. 1986 ). All of these manifestations are considered animal correlates of "depression," and the behavioral syndrome that fol lows withdrawal from amphetamine administration has been suggested as an experimental model of depres sion (Leith and Barret 1980) . Some of these changes are also reversed by tricyclic antidepressants (Markou et al. in press; Simpson 1974) .
It should be noted, however, that some endocrine, immune, and neurochemical changes observed during amphetamine withdrawal in rats do not parallel changes in the same systems observed during endogenous depression in humans . In the present study, a self-administration rather than experi· menter-administered procedure was employed. Under these conditions the animals showed a voluntary in-take of high doses of amphetamine. It is noteworthy that a recent report suggests that rats self-administering cocaine assume and tolerate doses that are toxic or le thal for yoked control individuals (Dworkin et al. 1988);  in contrast, no deaths were recorded during the pres ent study. The use of intravenous self-administration procedures would therefore have both the advantage of the self-titration of drug intake by each individual animal and a more "natural" temporal pattern of self injections (as compared to experimenter-administered procedures) and these may possibly be more closely related to the pattern of drug intake in human addicts.
The major fmding of the present report is the effect oflisuride on the behavioral changes described above.
Usuride is an ergot derivative known to stimulate brain DA receptors of the D2 type (Uzumaki et al. 1982; Horowski and Wachtel 1976; Schechter 1984; Cunning ham et al. 1987; Rosenfeld and Makman 1981) . Lisu ride also seems to affect serotonin (5-HT) neurotrans mission (Fink and Morgenstern 1985; Cunningham and lekowski 1990) . Indeed, there appears to be a serotoner giccomponent of its locomotor activity effects (Fink and Morgenstern 1985) and lisuride elicits the "serotonin syndrome" characteristic of 5-HT agonists (Sielbergeld and Hruska 1979) . Furthermore, a signifIcant propor tion of humans maintained on lisuride therapy report hall ucinations, which are thought to be mediated by 5oHT2 receptors (MacDonald and Horowski 1983) . In addition, interference with 5-HT neurotransmission has signifIcant effects on the self-administration of am phetamine and cocaine (Carroll et al. 1990, Loh and Roberts 1990) . It is therefore possible that this interac tion of lis uride with the 5-HT system is of relevance for the effects of reported treatment with lisuride also reported here.
In a recent report, lisuride reduced cocaine self administration (Pulvirenti and Koob submitted) . This supports the hypothesis that amphetamine, and other psycho stimulant drugs, produce their rewarding action by activating the forebrain DA system (for review, see Pulvirenti and Koob 1990) . The rationale for using lisu ride during postamphetamine withdrawal, in contrast, stems from the evidence that a state of DA depletion may occur during the withdrawal phase, as shown by experimental and clinical fmdings (Wyatt et al. 1988; Gawin and Kleber, 1985; Dackis and Gold, 1985b) . Ac cordingly, bromocriptine, a DA receptor agonist, was shown to decrease cocaine self-administration (Hub ner and Koob 1990) and to reverse behavioral signs of cocaine withdrawal in rats (Markou and Koob 1992) .
Furthermore, clinical studies suggest that bromocrip tine showed some benefIcial effect during cocaine withdrawal in humans (Dackis and Gold 1985a) . Since dysphoria and drug craving are particularly intense during the initial phase of withdrawal from psycho stimulant drugs, and these are considered important 
